Carter's stands as North America's largest dedicated baby and young children's apparel company, making its quarterly results a useful gauge of consumer demand for children's essentials. The firm has been navigating a multi-year turnaround backed by improved marketing, productivity efforts, and renewed strength in its core Baby segment. Its most recent quarter showed net sales up 5% and adjusted operating income up 54% year over year, though a one-time tariff refund provided some support. With Wall Street growing more cautious amid soft demand, higher input costs, and ongoing pressure from declining U.S. birth rates, this report will help clarify whether recent progress can hold up without temporary boosts.
For the third quarter of fiscal 2026, management has guided to approximately $750 million in net sales, about $50 million in adjusted operating income, and roughly $0.85 in adjusted diluted EPS. In the year-ago quarter, the company reported $757.84 million in net sales and $0.74 in adjusted diluted EPS. Consensus estimates sit in a comparable range, with analysts generally looking for EPS of roughly $0.85 to $0.89 and revenue near $750 million. This points to modest year-over-year earnings growth against a slightly softer top line. Notably, consensus EPS estimates have drifted lower over the past 60 days as caution grows around margin pressure from cotton and oil prices along with softer consumer demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Investors will pay close attention to U.S. Retail comparable sales, gross margin trends, and any updates to the full-year 2026 outlook, which currently calls for 2% to 3% net sales growth.
Sentiment heading into the report appears cautious. The stock recently traded near $32.60, toward the lower half of its 52-week range of roughly $27.86 to $44.44, and analyst ratings lean toward a neutral "Hold." Several firms have trimmed price targets in recent weeks, pointing to soft demand, unfavorable weather, and input-cost inflation. Elevated short interest also reflects meaningful skepticism about the turnaround. Because last quarter's results included a one-time tariff refund recovery, investors are likely to reward evidence of sustainable, organic operating improvement rather than another headline beat driven by non-operating items. A clean quarter with solid comparable sales and stable margins would carry more weight than EPS upside from temporary factors. Conversely, any disappointment on the top line or a downbeat fourth-quarter outlook could reinforce existing bearish positioning.
Beyond the headline numbers, several elements could influence results over the next several quarters. First, guidance for the fourth quarter and any commentary on fiscal 2027 comparisons will matter, given the holiday period's outsized contribution to annual earnings. Second, margin trends remain important. Carter's has noted incremental tariff costs and input inflation, and rising cotton and oil prices could pressure gross margins even as the company pursues pricing actions, tariff mitigation, and productivity savings. The balance between those savings and demand-creation investments will help determine whether profitability continues to improve. Third, the structural decline in U.S. birth rates means Carter's must increasingly gain market share through brand relevance, digital growth, and store-fleet rationalization. Progress in the Baby segment and e-commerce channel will serve as key indicators. Finally, the balance sheet and return of capital remain supportive with a quarterly dividend and continued buyback flexibility, though expectations should stay grounded in reported data and management guidance.
In my own review of names like this, I often turn to Tickeron's AI tools to cross-check patterns and peer comparisons quickly. The AI Screener stands out for filtering stocks by industry, technical signals, and performance metrics, helping surface ideas that might otherwise take longer to identify manually. It has become a regular part of how I build context around upcoming reports.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CRI broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 28 similar instances where the stock broke above the upper band. In 24 of the 28 cases the stock fell afterwards. This puts the odds of success at 86%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 60 cases where CRI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
The 50-day moving average for CRI moved below the 200-day moving average on September 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRI's RSI Indicator exited the oversold zone, 26 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on CRI as a result. In 63 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for CRI just turned positive on September 21, 2026. Looking at past instances where CRI's MACD turned positive, the stock continued to rise in 41 of 55 cases over the following month. The odds of a continued upward trend are 75%.
CRI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CRI crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +7.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in 194 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 116 of 189 cases where CRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.165) is normal, around the industry mean (1.830). P/E Ratio (6.082) is within average values for comparable stocks, (12.232). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (0.517). Dividend Yield (0.031) settles around the average of (0.067) among similar stocks. P/S Ratio (0.346) is also within normal values, averaging (0.652).
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. CRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of apparel and related products for babies and young children
Industry ApparelFootwearRetail